Eli Lilly and Company Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (35)

Latest Posts

About This Stock More About This Stock
Eli Lilly’s Fiscal 2016 Earnings: Analyzing The Surprising Results
Article By: SureDividend
Wednesday, February 1, 2017 3:52 PM EST
Eli Lilly has a solid 2.7% dividend yield. And, now that the company’s growth investments are bearing fruit, it has returned to dividend growth.
In this article: LLY
Read
Pfizer Inc. Shares Fall On Earnings Miss, Eli Lilly And Co. Little Changed On Sales Beat
Article By: ValueWalk
Tuesday, January 31, 2017 9:06 AM EST
Pfizer reported GAAP earnings of 13 cents per share, swinging from a loss of 3 cents per share in the year-ago quarter. Innovative Health revenues rose 1% to $7.7 billion, while Essential Health sales declined 8% to $5.9 billion.
In this article: LLY, PFE
Read
Drug Stocks Reporting Q4 Earnings On Jan 31: LLY And PFE
Article By: Zacks Investment Research
Monday, January 30, 2017 9:46 AM EST
Eli Lilly’s bottom-line performance has been mixed so far, with its earnings surpassing expectations in two of the last four quarters, and missing the same in the other two, bringing the average negative surprise to 2.05%.
In this article: PFE, LLY Also: BMY, JNJ, BIIB, CELG
Read
Earnings Growth Returns, Will It Continue?
Article By: Sheraz Mian
Saturday, January 28, 2017 5:54 PM EST
Corporate earnings have started growing again, with growth in the ongoing Q4 earnings season on track to reach its highest level in eight quarters.
In this article: AN, HSY, IP, LLY, PFE, XOM, AAPL, AMZN, CME, MSFT, FB, UA
Read
Eli Lilly Cancels Long Running Collaboration With Adocia
Article By: KKD Healthcare Analytics
Friday, January 27, 2017 2:09 PM EST
Eli Lilly and Co announced that it has terminated its collaboration with Adocia.
In this article: LLY
Read

PARTNER HEADLINES

Latest Tweets for $LLY

No tweets yet!